Pain Management: Chronic Clinical Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
- » Activity in other systems (incl. immunology and hormones)
- » Alternative and complementary therapies
- » Cancer pain (incl. non-malignant pain and palliative care)
- » Clinical assessment of pain (incl. diagnosis, long-term assessment and outcome measures)
- » Epidemiology and economics of chronic pain (e.g. pharmacoepidemiology)
- » Ethics
- » Interventional pain strategies
- » Neuropathic pain
- » Pain issues in sub-populations (incl. age and gender)
- » Pharmaceutical therapies (incl. side effects)
- » Physical therapies
- » Psychological and social aspects of pain and other comorbid issues
- » Rehabilitation (incl. assessment and therapies)
- » Site-related pain (e.g. headache and backache)
- » Somatic pain (incl. muscle pain)
- » Visceral pain
Chemotherapy-induced peripheral neuropathy is a major cause of morbidity and dose reduction for which there is very limited effective therapy. This randomized, double-blind, placebo-controlled crossover study suggests that use of duloxetine for 5 weeks significantly...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.